CLEC7A and cancer: The resulting Dox‐MSN‐PEI‐GPs (glucan particles) efficiently targeted NIH 3T3‐D1 cancer cells through Dectin‐1 and CR3 and inhibited tumor growth at a DOX concentration level below an effective free‐drug concentration.